These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 22223137)
21. Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells. Kigawa J; Sato S; Shimada M; Kanamori Y; Itamochi H; Terakawa N Gynecol Oncol; 2002 Feb; 84(2):210-5. PubMed ID: 11812076 [TBL] [Abstract][Full Text] [Related]
22. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo. Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641 [TBL] [Abstract][Full Text] [Related]
23. Enhanced apoptotic activity of a p53 variant in tumors resistant to wild-type p53 treatment. Atencio IA; Avanzini JB; Johnson D; Neuteboom S; Vaillancourt MT; Nielsen LL; Hajian G; Sutjipto S; Sugarman BJ; Philopena J; McAllister DL; Beltran JC; Nodelman M; Ramachandra M; Wills KN Mol Ther; 2001 Jul; 4(1):5-12. PubMed ID: 11472100 [TBL] [Abstract][Full Text] [Related]
25. Time-dependent changes in factors involved in the apoptotic process in human ovarian cancer cells as a response to cisplatin. Kolfschoten GM; Hulscher TM; Schrier SM; van Houten VM; Pinedo HM; Boven E Gynecol Oncol; 2002 Mar; 84(3):404-12. PubMed ID: 11855878 [TBL] [Abstract][Full Text] [Related]
26. COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines. O'Kane SL; Eagle GL; Greenman J; Lind MJ; Cawkwell L Lung Cancer; 2010 Feb; 67(2):160-5. PubMed ID: 19450893 [TBL] [Abstract][Full Text] [Related]
27. The p53-reactivating small-molecule RITA enhances cisplatin-induced cytotoxicity and apoptosis in head and neck cancer. Roh JL; Ko JH; Moon SJ; Ryu CH; Choi JY; Koch WM Cancer Lett; 2012 Dec; 325(1):35-41. PubMed ID: 22634494 [TBL] [Abstract][Full Text] [Related]
28. Sensitization by glycerol for CDDP-therapy against human cultured cancer cells and tumors bearing mutated p53 gene. Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Yane K; Kanata H; Okamoto N; Hosoi H; Ohnishi T Apoptosis; 2004 Nov; 9(6):853-9. PubMed ID: 15505427 [TBL] [Abstract][Full Text] [Related]
29. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF; Xie L; McDonald M; DiGiacomo R; Chang A; Gurnani M; Shi B; Liu S; Indelicato SR; Hutchins B; Nielsen LL Cancer Gene Ther; 2000 Nov; 7(11):1469-80. PubMed ID: 11129289 [TBL] [Abstract][Full Text] [Related]
30. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630 [TBL] [Abstract][Full Text] [Related]
31. The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma. Stewart JH; Tran TL; Levi N; Tsai WS; Schrump DS; Nguyen DM J Surg Res; 2007 Jul; 141(1):120-31. PubMed ID: 17574045 [TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734 [TBL] [Abstract][Full Text] [Related]
33. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Weber HO; Samuel T; Rauch P; Funk JO Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636 [TBL] [Abstract][Full Text] [Related]
34. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells. Yang CT; You L; Yeh CC; Chang JW; Zhang F; McCormick F; Jablons DM J Natl Cancer Inst; 2000 Apr; 92(8):636-41. PubMed ID: 10772681 [TBL] [Abstract][Full Text] [Related]
35. Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species. Yang YI; Kim JH; Lee KT; Choi JH Gynecol Oncol; 2011 Dec; 123(3):588-96. PubMed ID: 21945308 [TBL] [Abstract][Full Text] [Related]
36. Phase I and pharmacokinetic study of pemetrexed plus cisplatin in chemonaive patients with locally advanced or metastatic malignant pleural mesothelioma or non-small cell lung cancer. Dickgreber NJ; Fink TH; Latz JE; Hossain AM; Musib LC; Thomas M Clin Cancer Res; 2009 Jan; 15(1):382-9. PubMed ID: 19118069 [TBL] [Abstract][Full Text] [Related]
37. MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53. Walter RF; Mairinger FD; Ting S; Vollbrecht C; Mairinger T; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J Br J Cancer; 2015 Mar; 112(5):883-90. PubMed ID: 25668009 [TBL] [Abstract][Full Text] [Related]
38. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152 [TBL] [Abstract][Full Text] [Related]
39. Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation, and chemotherapy. Huber PE; Bischof M; Jenne J; Heiland S; Peschke P; Saffrich R; Gröne HJ; Debus J; Lipson KE; Abdollahi A Cancer Res; 2005 May; 65(9):3643-55. PubMed ID: 15867359 [TBL] [Abstract][Full Text] [Related]